Hologic (Nasdaq: HOLX) announced today that it has expanded its Omni suite of gynecological surgical offerings in Europe, Africa and western Asia.
The Omni expansion gives physicians greater flexibility and choice as they optimize diagnostic and operative hysteroscopy, according to the Marlborough, Massachusetts–based women’s health company.
“The option to ‘see and treat’ is becoming more common across Europe. There is an increasing awareness of the benefits of moving these types of procedures to the outpatient environment, and this has been further highlighted by the pandemic,” said Tanja Brycker, VP of strategic development BSH & Surgical – International at Hologic.
Brycker said in a news release that gynecologists need to have access to a broader range of products that enable them to adapt quickly to the requirements of each patient. “Hologic has consulted extensively with our customers, and the latest additions to the Omni suite of hysteroscopic products were developed based on their feedback.”